RT Journal Article
SR Electronic
T1 Incidence of SARS-CoV-2 infection among asymptomatic frontline health workers in Los Angeles County, California
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.18.20234211
DO 10.1101/2020.11.18.20234211
A1 Megan Halbrook
A1 Adva Gadoth
A1 Rachel Martin-Blais
A1 Ashley Grey
A1 Deisy Contreras
A1 Saman Kashani
A1 Clayton Kazan
A1 Brian Kane
A1 Nicole H. Tobin
A1 Jennifer A. Fulcher
A1 Sarah L. Brooker
A1 Scott G. Kitchen
A1 Emmanuelle Faure-Kumar
A1 Otto O. Yang
A1 Kathie G. Ferbas
A1 Grace M. Aldrovandi
A1 Anne W. Rimoin
YR 2020
UL http://medrxiv.org/content/early/2020/11/21/2020.11.18.20234211.abstract
AB Beginning April 8, 2020, we enrolled 1787 frontline heath workers who were asymptomatic for COVID-19 into a longitudinal surveillance study. During that time 4 healthcare workers and 6 first responders tested positive for SARS-CoV-2 by RT-PCR. Additionally, 43 healthcare workers and 55 first responders had detectable IgG antibodies to SARS-CoV-2.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by lead funders AIDS Healthcare Foundation, The Shurl and Kay Curci Foundation, Elizabeth R. Koch Foundation, The Horn Foundation, and Steven & Alexandra Cohen Foundation, and many others who have also given generously to facilitate this research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the UCLA institutional review board on March 25, 2020, IRB# 20-000478.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is not publicly available but interested parties should contact study authors for inquiries regarding data access.